Q3 2014 Holdings
Filed 2014-11-13 | 132 holdings | $38.4M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2014-11-20) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abbvie Inc(ABBV)A | COM | 00287Y109 | $23.3M | 403,550 | 60.6% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $8.8M | 121,970 | 22.9% |
| Catalyst Pharmaceutical Part(CPRX) | COM | 14888U101 | $2.3M | 685,500 | 5.9% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $2.0M | 89,817 | 5.2% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $1.3M | 363,212 | 3.3% |
| Novartis AG-Reg(NVSN)A | SPONSORED ADR | 66987V109 | $45.2K | 478,921 | 0.1% |
| Spdr S&P 500 ETF TrustPutA | PUT | 78464A950 | $39.4K | 200,000 | 0.1% |
| Pfizer Inc(PFE) | COM | 717081103 | $37.7K | 1,274,013 | 0.1% |
| Teva Pharmaceutical(TEVA)A | ADR | 881624209 | $34.8K | 647,438 | 0.1% |
| Health Care Select Sector SpdrPutA | PUT | 81369Y959 | $31.0K | 485,500 | 0.1% |
| Actavis PLC | SHS | G0083B108 | $29.5K | 122,100 | 0.1% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $25.0K | 405 | 0.1% |
| Merck & Co. Inc.(MRK) | COM | 58933Y105 | $24.8K | 417,530 | 0.1% |
| Allergan Inc | COM | 18490102 | $23.0K | 128,840 | 0.1% |
| Shire PLC | SPONSORED ADR | 82481R106 | $22.4K | 259,085 | 0.1% |
| Isramco Negev 2 LPA | COM NEW | 465141406 | $22.1K | 103,111,944 | 0.1% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $22.1K | 207,406 | 0.1% |
| Gilead Sciences IncCallA | CALL | 375558903 | $20.7K | 194,200 | 0.1% |
| Teva Pharmaceutical IndustriesCallA | CALL | 881624909 | $20.2K | 375,200 | 0.1% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $16.8K | 150,000 | 0.0% |
| Glaxosmithkline PLCCallA | CALL | 37733W905 | $13.4K | 291,300 | 0.0% |
| Valeant Pharmaceuticals Inte | COM | 91911K102 | $12.9K | 98,550 | 0.0% |
| Valeant Pharmaceuticals InteCallA | CALL | 91911K902 | $12.8K | 97,200 | 0.0% |
| Mallinckrodt PLC | SHS | G5785G107 | $12.3K | 135,940 | 0.0% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $11.4K | 88,840 | 0.0% |
| Israel Chemicals Ltd(ICL)A | SHS | M5920A109 | $10.0K | 1,380,000 | 0.0% |
| Elbit Systems Ltd(ESLT)A | ORD | M3760D101 | $9.0K | 144,759 | 0.0% |
| Orbotech LtdA | ORD | M75253100 | $8.9K | 571,532 | 0.0% |
| Astrazeneca PLC | SPONSORED ADR | 46353108 | $8.6K | 120,000 | 0.0% |
| Verint Systems Inc(VTY)A | COM | 92343X100 | $8.4K | 151,468 | 0.0% |
| Sanofi | RIGHT 12/31/2020 | 80105N113 | $7.7K | 67,960 | 0.0% |
| Salix Pharmaceuticals LTDCallA | CALL | 795435906 | $7.6K | 48,500 | 0.0% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $7.2K | 30,296 | 0.0% |
| Astrazeneca PLCCallA | CALL | 46353908 | $6.9K | 97,100 | 0.0% |
| Amgen Inc | COM | 31162100 | $6.8K | 48,550 | 0.0% |
| Acorda Therapeutics Inc | COM | 00484M106 | $6.7K | 199,105 | 0.0% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $6.3K | 97,100 | 0.0% |
| Medivation Inc | COM | 58501N101 | $6.2K | 63,115 | 0.0% |
| B Communications LtdA | SHS | M15629104 | $6.2K | 321,431 | 0.0% |
| Meda AB-A SHS | COM | 584045108 | $6.1K | 433,889 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $5.8K | 155,360 | 0.0% |
| Dyax Corp | COM | 26746E103 | $5.2K | 517,556 | 0.0% |
| Apple IncA | COM | 37833100 | $5.0K | 50,045 | 0.0% |
| Ituran Location and Control Lt(ITRN)A | SHS | M6158M104 | $4.9K | 231,115 | 0.0% |
| Amag Pharmaceuticals Inc(AMAG) | COM | 00163U106 | $4.8K | 150,230 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $4.6K | 101,955 | 0.0% |
| Pharmacyclics Inc | COM | 716933106 | $4.6K | 38,840 | 0.0% |
| CSX Corp(CSX)A | COM | 126408103 | $4.5K | 139,675 | 0.0% |
| Glaxosmithkline PLC | SPONSORED ADR | 37733W105 | $4.5K | 97,100 | 0.0% |
| Mylan Inc | COM | 628530107 | $4.4K | 97,100 | 0.0% |